INS and type 1 diabetes mellitus: Since insulins and analogues are used by both patients with Type 1 diabetes and Type 2 diabetes, the definition applied in the outcome measure “prevalent user of insulins only” is aimed at estimating a group of patients with Type 1 diabetes.